Literature DB >> 21504695

Compositae-associated allergic contact dermatitis from bisabolol.

Sharon E Jacob1, Catalina Matiz, Elise M Herro.   

Abstract

BACKGROUND: Compositae-related chemicals cause allergic contact dermatitis (ACD) in children with atopic dermatitis (AD). Moisturizers can be an overlooked exposure source.
OBJECTIVE: To evaluate ACD in children with recalcitrant AD and a reported history of intolerance to Aquaphor Healing Ointment (AHO) moisturizer.
METHODS: We retrospectively reviewed charts of children patch-tested to the ingredients of AHO moisturizer who had a history of intolerance, as well as of additional patch-tested patients with exposure to bisabolol in their personal hygiene products and without a history of product intolerance.
RESULTS: Seven patients, six of whom had AD, had been referred to our clinic with a history of intolerance to the moisturizer. They were patch-tested with their moisturizer and the components provided by Beiersdorf. Of these, four had positive reactions to their AHO moisturizer and to bisabolol, a Compositae derivative.
CONCLUSION: Bisabolol, a sesquiterpene alcohol, should be considered a potential cause of ACD in children with AD and a history of moisturizer intolerance.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21504695

Source DB:  PubMed          Journal:  Dermatitis        ISSN: 1710-3568            Impact factor:   4.845


  2 in total

1.  Invited commentary: recommendation for a north american pediatric patch test series.

Authors:  Sharon E Jacob; Shehla Admani; Elise M Herro
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

2.  Clinical efficacy of new α-bisabolol mouthwashes in postoperative complications of maxillofacial surgeries: a randomized, controlled, triple-blind clinical trial.

Authors:  Bruno Frota Amora-Silva; S C Ribeiro; C L Vieira; F R Mendes; A E Vieira-Neto; A P V Abdon; F N Costa; A R Campos
Journal:  Clin Oral Investig       Date:  2018-05-03       Impact factor: 3.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.